Skill Development & Hands-on-Training on Quality Control of Biologicals Programme for M.Sc. Biotechnology students of Universities of Jammu, Kashmir, North East and Himachal Pradesh at NIB Laboratories from 09th Februay 2016 to 1st March 2016.   NIB may revise the Fee/charges for the testing of various biological products with effect from 01/01/2016.   NIB laboratories such as Blood Grouping Reagent (Blood Reagents), Immunodiagnostic Kit (Human Immunodeficiency Virus, Hepatitis B Surface Antigen, Hepatitis C virus), Blood Products (Human Albumin, Human Normal Immunoglobulin(Intramuscular and Intravenous), Human Coagulation Factor VIII, Human Coagulation Factor IX, Plasma Protein Fractionation, Fibrin Sealant Kit, Anti Inhibitor Coagulation Complex), Recombinant Products (Recombinant Insulin and Insulin analogues, r-erythropoietin (EPO), r-Granulocyte Colony Stimulating Factor(G-CSF) and Biochemical Kits(Glucose Test Strips, Fully Automated Analyser Based Glucose Reagents) notified as Central Drugs Laboratory.   NIB Scientists notified as Government Analysts are Dr. Reba Chhabra, Dr. Renu Jain, Dr. J.P. Prasad, Ms. Ajanta Sircar and Ms.Kanchan Ahuja.   Dr Surinder Singh, Director, NIB ranked among top list of world's most influential people third time in row.   

Locale of the Administrative Block
BSL-2 spacious State of the Art Laboratory Block
Product Testing Laboratories
Hands on Training during Workshops at NIB
  1. National Institute of Biologicals an autonomous Institution under the Ministry of Health & Family Welfare (MOHFW)-Government of India is a premier Scientific Organization and a Centre of Excellence to ensure quality of biologicals and vaccines in the country.
  2. The institute responsibly assures and reviews the quality of number of  Biological products available through domestic manufacturers or imports. The operations are carried out in the state of the art Facility of the Institute and in close coordination with Government of India regulatory authorities as Office of Drug Controller of India, Indian Pharmacopeia's Commission.
    With the current science and technology leading to the development of newer biologicals in the domestic market,  the testing and specifications may vary for each specific products which  requires  an improved understanding of quality and safety issues.In recent years the licensing and quality control for manufacturer and National Regulatory Authorities alike has become even more complex. With this overall objective and to strengthen the regulations of biologicals in India, NIB, which is supported by the authorities constituted of Governing body and General body of the Institute plays a vital role.


Sample Receipt & Report Dispatch Unit National Reference Standards Sera Panel

Manufacturing and QC Protocols


Sample Receipt and Report Dispatch Unit  (SRRDU) Procedure.

  •  SRRDU  has been set up as independent unit in 2008.   The sample receipt unit being the main entry point of all samples to the Institute for testing, this unit has been accredited by NABL for elaborate documentation procedures. The Standard Operating Procedures (SOPs) have been amended to regulate Sample receipt to make the system flexible

  • more>>


Sample Receipt Format


Turnaround time for testing 





Monograph for

Anti-D-IgM(Monoclonal)  till 14.09.2015




  Guidance Documents on Laboratories Tab 


Front Gate